Sclerotic lesions can be malignant or benign. They are usually localized to a single bone or area of your body. A malignant lesion is often cancerous, posing a risk to your health if it is not treated ...

—In a new study, the extent of microstructural damage in patients with early relapsing-remitting multiple sclerosis (RRMS) was associated with worse disability and spinal cord atrophy at 5 years. Here ...

Even with disease-modifying therapies, patients who have chronically active inflammatory MS lesions can expect an aggressive disease course and poor outcomes. A new study shows that patients with ≥4 ...

Using advanced methodology, scientists have been able to reveal at the cellular level how lesions in multiple sclerosis develop. Using advanced methodology, scientists in Sweden were able to reveal at ...

Collaborating scientists at the Karolinska Institute and at Stockholm University used a technology called in situ sequencing (ISS) to help reveal at the cellular level how lesions in multiple ...

In contrast to traditional measures, such as an increase or worsening of lesions or overall brain atrophy, to signal progression of multiple sclerosis (MS), investigators are proposing atrophied ...

The diagnostic criteria for MS reflect a growing understanding of the condition and the application of new advancements in medical technology to help improve diagnostic accuracy and reliability.

Using advanced methodology, scientists in Sweden were able to reveal at the cellular level how lesions in multiple sclerosis develop. The new results are presented in the journal Cell by researchers ...

A Cedars-Sinai study has identified a previously unknown role for astrocyte cells in how the brain responds to damage and ...

A 29 year-old woman presented with loss of coordination affecting the right arm and leg. Multiple Sclerosis (MS): (Left and Middle) Flair axial MRIs; (Right) T1-weighted with gadolinium (GAD) axial ...